Achieve Life Sciences, Inc. Operating Cash Flow
Achieve Life Sciences, Inc. (ACHV) reported Operating Cash Flow of -$17.71 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-11
- Achieve Life Sciences, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$10.78M.
- Achieve Life Sciences, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$6.93M.
- Achieve Life Sciences, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$17.98M.
- Achieve Life Sciences, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$11.33M.
- Achieve Life Sciences, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$49.47M.
- Achieve Life Sciences, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$29.77M.
- Achieve Life Sciences, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$24.48M.
- Achieve Life Sciences, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$37.57M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$10.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$17.71M 10-Q · filed 2026-08-11 | -$35.69M derived: sum of 3 quarters · filed 2026-08-11 | -$47.02M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2026-03-31 | -$6.93M 10-Q · filed 2026-05-12 | -$24.91M derived: sum of 2 quarters · filed 2026-05-12 | -$36.24M derived: sum of 3 quarters · filed 2026-05-12 | -$45.31M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-12-31 | -$17.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$29.31M derived: sum of 2 quarters · filed 2026-03-24 | -$38.38M derived: sum of 3 quarters · filed 2026-08-11 | -$49.47M 10-K · filed 2026-03-24 | |||
| 2025-09-30 | -$11.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$20.40M derived: sum of 2 quarters · filed 2026-08-11 | -$31.49M 10-Q · filed 2025-11-06 | -$40.68M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-06-30 | -$9.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$20.16M 10-Q · filed 2026-08-11 | -$29.35M derived: sum of 3 quarters · filed 2026-08-11 | -$39.72M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-03-31 | -$11.09M 10-Q · filed 2026-05-12 | -$20.28M derived: sum of 2 quarters · filed 2026-05-12 | -$30.65M derived: sum of 3 quarters · filed 2026-05-12 | -$35.57M derived: sum of 4 quarters · filed 2026-05-12 | |||
| 2024-12-31 | -$9.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$19.56M derived: sum of 2 quarters · filed 2026-03-24 | -$24.48M derived: sum of 3 quarters · filed 2026-03-24 | -$29.77M 10-K · filed 2026-03-24 | |||
| 2024-09-30 | -$10.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$15.29M derived: sum of 2 quarters · filed 2025-11-06 | -$20.58M 10-Q · filed 2025-11-06 | -$24.95M derived: sum of 4 quarters · filed 2026-03-24 | |||
| 2024-06-30 | -$4.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$10.21M 10-Q · filed 2025-08-07 | -$14.57M derived: sum of 3 quarters · filed 2026-03-24 | -$19.71M derived: sum of 4 quarters · filed 2026-03-24 | |||
| 2024-03-31 | -$5.29M 10-Q · filed 2025-05-13 | -$9.65M derived: sum of 2 quarters · filed 2026-03-24 | -$14.79M derived: sum of 3 quarters · filed 2026-03-24 | -$21.46M derived: sum of 4 quarters · filed 2026-03-24 | |||
| 2023-12-31 | -$4.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$9.50M derived: sum of 2 quarters · filed 2026-03-24 | -$16.18M derived: sum of 3 quarters · filed 2026-03-24 | -$24.48M 10-K · filed 2026-03-24 | |||
| 2023-09-30 | -$5.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$11.81M derived: sum of 2 quarters · filed 2024-11-07 | -$20.11M 10-Q · filed 2024-11-07 | -$31.26M derived: sum of 4 quarters · filed 2025-03-11 | |||
| 2023-06-30 | -$6.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$14.98M 10-Q · filed 2024-08-13 | -$26.12M derived: sum of 3 quarters · filed 2025-03-11 | -$37.43M derived: sum of 4 quarters · filed 2025-03-11 | |||
| 2023-03-31 | -$8.30M 10-Q · filed 2024-05-09 | -$19.45M derived: sum of 2 quarters · filed 2025-03-11 | -$30.75M derived: sum of 3 quarters · filed 2025-03-11 | -$39.09M derived: sum of 4 quarters · filed 2025-03-11 | |||
| 2022-12-31 | -$11.14M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$22.45M derived: sum of 2 quarters · filed 2025-03-11 | -$30.79M derived: sum of 3 quarters · filed 2025-03-11 | -$37.57M 10-K · filed 2025-03-11 | -$37.55M 10-K · filed 2023-03-16 | ||
| 2022-09-30 | -$11.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$19.65M derived: sum of 2 quarters · filed 2023-11-09 | -$26.43M 10-Q · filed 2023-11-09 | -$26.41M 10-Q · filed 2022-11-14 | -$31.64M derived: sum of 4 quarters · filed 2024-03-28 | ||
| 2022-06-30 | -$8.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$15.12M 10-Q · filed 2023-08-14 | -$15.10M 10-Q · filed 2022-08-11 | -$20.34M derived: sum of 3 quarters · filed 2024-03-28 | -$29.03M derived: sum of 4 quarters · filed 2024-03-28 | ||
| 2022-03-31 | -$6.78M 10-Q · filed 2023-05-09 | -$12.00M derived: sum of 2 quarters · filed 2024-03-28 | -$20.69M derived: sum of 3 quarters · filed 2024-03-28 | -$29.77M derived: sum of 4 quarters · filed 2024-03-28 | |||
| 2021-12-31 | -$5.22M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$13.91M derived: sum of 2 quarters · filed 2024-03-28 | -$22.99M derived: sum of 3 quarters · filed 2024-03-28 | -$29.44M 10-K · filed 2024-03-28 | |||
| 2021-09-30 | -$8.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$17.77M derived: sum of 2 quarters · filed 2022-11-14 | -$24.22M 10-Q · filed 2022-11-14 | -$26.70M derived: sum of 4 quarters · filed 2023-03-16 | |||
| 2021-06-30 | -$9.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$15.53M 10-Q · filed 2022-08-11 | -$18.01M derived: sum of 3 quarters · filed 2023-03-16 | -$22.34M derived: sum of 4 quarters · filed 2023-03-16 | |||
| 2021-03-31 | -$6.45M 10-Q · filed 2022-05-12 | -$8.93M derived: sum of 2 quarters · filed 2023-03-16 | -$13.27M derived: sum of 3 quarters · filed 2023-03-16 | -$15.46M derived: sum of 4 quarters · filed 2023-03-16 | |||
| 2020-12-31 | -$2.48M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$6.82M derived: sum of 2 quarters · filed 2023-03-16 | -$9.01M derived: sum of 3 quarters · filed 2023-03-16 | -$13.47M 10-K · filed 2023-03-16 | |||
| 2020-09-30 | -$4.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$6.53M derived: sum of 2 quarters · filed 2021-11-09 | -$10.99M 10-Q · filed 2021-11-09 | -$14.41M derived: sum of 4 quarters · filed 2022-03-10 | |||
| 2020-06-30 | -$2.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$6.66M 10-Q · filed 2021-08-12 | -$10.07M derived: sum of 3 quarters · filed 2022-03-10 | -$13.14M derived: sum of 4 quarters · filed 2022-03-10 | |||
| 2020-03-31 | -$4.46M 10-Q · filed 2021-05-13 | -$7.88M derived: sum of 2 quarters · filed 2022-03-10 | -$10.95M derived: sum of 3 quarters · filed 2022-03-10 | -$14.79M derived: sum of 4 quarters · filed 2022-03-10 | |||
| 2019-12-31 | -$3.41M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$6.49M derived: sum of 2 quarters · filed 2022-03-10 | -$10.33M derived: sum of 3 quarters · filed 2022-03-10 | -$15.22M 10-K · filed 2022-03-10 | |||
| 2019-09-30 | -$3.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$6.91M derived: sum of 2 quarters · filed 2020-11-12 | -$11.80M 10-Q · filed 2020-11-12 | -$15.34M derived: sum of 4 quarters · filed 2021-03-11 | |||
| 2019-06-30 | -$3.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$8.73M 10-Q · filed 2020-08-06 | -$12.27M derived: sum of 3 quarters · filed 2021-03-11 | -$15.25M derived: sum of 4 quarters · filed 2021-03-11 | |||
| 2019-03-31 | -$4.89M 10-Q · filed 2020-05-14 | -$8.43M derived: sum of 2 quarters · filed 2021-03-11 | -$11.41M derived: sum of 3 quarters · filed 2021-03-11 | -$13.28M derived: sum of 4 quarters · filed 2021-03-11 | |||
| 2018-12-31 | -$3.54M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$6.52M derived: sum of 2 quarters · filed 2021-03-11 | -$8.39M derived: sum of 3 quarters · filed 2021-03-11 | -$10.62M 10-K · filed 2021-03-11 | |||
| 2018-09-30 | -$2.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$4.85M derived: sum of 2 quarters · filed 2019-11-06 | -$7.08M 10-Q · filed 2019-11-06 | -$10.71M derived: sum of 4 quarters · filed 2020-03-13 | |||
| 2018-06-30 | -$1.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$4.10M 10-Q · filed 2019-08-08 | -$7.72M derived: sum of 3 quarters · filed 2020-03-13 | -$13.18M derived: sum of 4 quarters · filed 2020-03-13 | |||
| 2018-03-31 | -$2.23M 10-Q · filed 2019-05-15 | -$5.86M derived: sum of 2 quarters · filed 2020-03-13 | -$11.31M derived: sum of 3 quarters · filed 2020-03-13 | ||||
| 2017-12-31 | -$3.62M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | -$9.08M derived: sum of 2 quarters · filed 2020-03-13 | -$9.11M 10-K · filed 2020-03-13 | ||||
| 2017-09-30 | -$5.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$5.48M 10-Q · filed 2018-11-07 | |||||
| 2017-06-30 | -$29.00K 10-Q · filed 2018-08-08 | ||||||
| 2016-12-31 | -$202.00K 10-K · filed 2019-03-14 | ||||||
| 2013-12-31 | -$7.54M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | -$17.77M derived: sum of 2 quarters · filed 2014-03-11 | -$25.24M derived: sum of 3 quarters · filed 2014-03-11 | -$35.93M 10-K · filed 2014-03-11 | |||
| 2013-09-30 | -$10.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$17.70M derived: sum of 2 quarters · filed 2013-11-07 | -$28.39M 10-Q · filed 2013-11-07 | -$37.89M derived: sum of 4 quarters · filed 2014-03-11 | |||
| 2013-06-30 | -$7.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$18.16M 10-Q · filed 2013-08-08 | -$27.66M derived: sum of 3 quarters · filed 2014-03-11 | -$40.59M derived: sum of 4 quarters · filed 2014-03-11 | |||
| 2013-03-31 | -$10.69M 10-Q · filed 2013-05-02 | -$20.19M derived: sum of 2 quarters · filed 2014-03-11 | -$33.12M derived: sum of 3 quarters · filed 2014-03-11 | -$46.80M derived: sum of 4 quarters · filed 2014-03-11 | |||
| 2012-12-31 | -$9.50M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | -$22.43M derived: sum of 2 quarters · filed 2014-03-11 | -$36.11M derived: sum of 3 quarters · filed 2014-03-11 | -$43.49M 10-K · filed 2014-03-11 | |||
| 2012-09-30 | -$12.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$26.61M derived: sum of 2 quarters · filed 2013-11-07 | -$34.00M 10-Q · filed 2013-11-07 | -$38.44M derived: sum of 4 quarters · filed 2014-03-11 | |||
| 2012-06-30 | -$13.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$21.06M 10-Q · filed 2013-08-08 | -$25.50M derived: sum of 3 quarters · filed 2014-03-11 | -$31.69M derived: sum of 4 quarters · filed 2014-03-11 | |||
| 2012-03-31 | -$7.38M 10-Q · filed 2013-05-02 | -$11.82M derived: sum of 2 quarters · filed 2014-03-11 | -$18.02M derived: sum of 3 quarters · filed 2014-03-11 | -$23.60M derived: sum of 4 quarters · filed 2014-03-11 | |||
| 2011-12-31 | -$4.44M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | -$10.63M derived: sum of 2 quarters · filed 2014-03-11 | -$16.22M derived: sum of 3 quarters · filed 2014-03-11 | -$20.26M 10-K · filed 2014-03-11 | |||
| 2011-09-30 | -$6.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -$11.78M derived: sum of 2 quarters · filed 2012-11-08 | -$15.82M 10-Q · filed 2012-11-08 | -$19.53M derived: sum of 4 quarters · filed 2013-03-07 | |||
| 2011-06-30 | -$5.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | -$9.63M 10-Q · filed 2012-08-02 | -$13.34M derived: sum of 3 quarters · filed 2013-03-07 | -$18.71M derived: sum of 4 quarters · filed 2013-03-07 | |||
| 2011-03-31 | -$4.04M 10-Q · filed 2012-05-03 | -$7.75M derived: sum of 2 quarters · filed 2013-03-07 | -$13.13M derived: sum of 3 quarters · filed 2013-03-07 | ||||
| 2010-12-31 | -$3.71M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | -$9.08M derived: sum of 2 quarters · filed 2013-03-07 | -$26.84M 10-K · filed 2013-03-07 | ||||
| 2010-09-30 | -$5.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | -$23.13M 10-Q · filed 2011-11-03 | |||||
| 2010-06-30 | -$17.76M 10-Q · filed 2011-08-05 | ||||||
| 2009-12-31 | $34.88M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |